What's new

[PIO] Announcement by the Ministry of Health for the administration of a booster dose of COVID-19 vaccine

30495.jpg





The Ministry of Health in the context of efforts to strengthen the immunity of the population against COVID-19, informs about the recommendations of the National Advisory Committee on Vaccination for the administration of the booster dose with the updated twin vaccines including the BA.1 sub-variants, BA.4 and BA.5 of the Omicron variant (More information: https:/bit.ly/3M6JXgm).

Note that completion of primary vaccination is required before administering an updated vaccine, regardless of which vaccines were administered.

From tomorrow, 6 October 2022, it is recommended to administer a booster/5th dose with the updated COVID-19 vaccines, provided that a period of five (5) months has elapsed since the last dose in persons who have already been vaccinated with the booster/4th vaccine dose.

Recall that:

  1. the booster/3rd dose is given to persons 12 years of age and older, provided that a period of five (5) months has elapsed since the last dose of vaccine/
  2. the booster/4thdose is administered: [*]to persons over 30 years of age, [*]to persons living or working in sheltered housing and closed facilities regardless of age, [*]to health care professionals regardless of age, to persons over 12 years of age with:
    1. diabetes mellitus,
    2. severe obesity: BMI ≥40 or ≥35 with metabolic syndrome,
    3. severe chronic respiratory disease,
    4. severe chronic cardiovascular disease,
    5. severe chronic kidney disease,
    6. severe chronic liver disease,
    7. severe chronic neurological disease,
    8. haemoglobinopathies,
    9. immunodeficiency and immunosuppression such as:

- with active treatment for solid tumors and hematologic malignancies,

- with a history of solid organ transplantation receiving immunosuppressive therapy,

- with a history of primary hematopoietic organ transplantation receiving immunosuppressive therapy,

- with hereditary immunodeficiency,

- with HIV infection/AIDS,

- with immunosuppressive therapy including biological agents,

- with renal failure undergoing dialysis or peritoneal dialysis,

- with regard to cortisone intake,

- with regard to cortisone intake refers to subjects who have received or are receiving a total dose of '10 mg prednisone/day (=8 mg methylprednisolone) for one (1) month in the last six months,

provided that a period of five (5) months has elapsed since receiving the booster/3rd dose of vaccine.

Receiving a booster dose of vaccine during COVID-19 is optional.

The vaccine *Moderna (BA.1) is available every Tuesday and Thursday

Vaccine **Pfizer/BioNTech (BA.4 and BA.5) is available daily from Monday to Friday.

Beneficiaries will be able to be served through the free-attendance vaccination centres (walk-in) operating in all provinces.

In order to be vaccinated

:

  1. Identification document (identity card, passport) and vaccination card.
  2. Professional Licence, issued by the Health Professionals.
  3. Medical certificate (from Staff or Specialist Doctor) from immunocompromised and immunosuppressed patients, as well as from persons with chronic serious illness or obesity.

Vaccination centres:

Nicosia: State Fair (8am - 2:30pm)

Larnaca: Larnaca Old Hospital (8am - 2:30pm)

Limassol: Linopetra Health Centre (8am - 2:30pm)

Paphos: Paphos General Hospital (8am - 2:30pm)

Famagusta: Famagusta Health Centre (8am - 2:30pm)

Kyperounda: Kyperounda Vaccination Centre (former SPC) Mondays, Wednesdays and Fridays (9:30am - 1:30pm)

Polis Chrysochous: Polis Chrysochous Hospital, every Tuesday (9:30am.p.m. - 1:30p.m.)

*The Moderna vaccine covers both the original virus strain and the BA.1 subtype

. of the Omicron variant.

**ThePfizer/BioNTech vaccine covers both the original virus strain and the BA.4 and BA.5 sub-variant of the Omicron variant.

(AF)
Contents of this article including associated images are belongs to PIO
Views & opinions expressed are those of the author and/or PIO

Source

 
Back
Top